Table 5.
Tracking interval | Study sample of subgroups | No competing risk in the model | Competing risk in the model | ||||
---|---|---|---|---|---|---|---|
Adjusted HR | 95% CI | P | Adjusted HR | 95% CI | P | ||
Whole period | Total | 0.777 | 0.582–1.298 | 0.236 | 0.764 | 0.538–1.086 | 0.133 |
Schizophrenia | 0.528 | 0.316–1.203 | 0.308 | 0.518 | 0.304–1.023 | 0.152 | |
Bipolar disorder | 1.692 | 0.605–2.861 | 0.267 | 1.616 | 0.584–2.385 | 0.228 | |
Major depressive disorder | 0.942 | 0.604–3.460 | 0.249 | 0.865 | 0.563–2.919 | 0.208 | |
0–1 year | Total | 0.991 | 0.651–1.508 | 0.264 | 0.971 | 0.638–1.478 | 0.213 |
Schizophrenia | 0.673 | 0.353–1.398 | 0.297 | 0.660 | 0.346–1.370 | 0.277 | |
Bipolar disorder | 2.158 | 0.677–3.324 | 0.342 | 2.115 | 0.663–3.238 | 0.322 | |
Major depressive disorder | 1.201 | 0.676–4.020 | 0.254 | 1.177 | 0.662–3.940 | 0.224 | |
3–6 years | Total | 1.821 | 0.728–4.556 | 0.200 | 1.782 | 0.714–4.469 | 0.198 |
Schizophrenia | 1.237 | 0.398–4.224 | 0.135 | 1.211 | 0.390–4.414 | 0.112 | |
Bipolar disorder | 7.635 | 0.837–23.627 | 0.264 | 7.490 | 0.821–23.178 | 0.245 | |
Major depressive disorder | 2.207 | 0.756–12.148 | 0.346 | 2.165 | 0.742–11.187 | 0.313 | |
≧6 years | Total | 0.685 | 0.513–2.065 | 0.123 | 0.671 | 0.502–2.024 | 0.114 |
Schizophrenia | 0.462 | 0.278–1.060 | 0.377 | 0.452 | 0.272–1.038 | 0.376 | |
Bipolar disorder | 1.491 | 0.533–2.521 | 0.277 | 1.460 | 0.522–2.486 | 0.273 | |
Major depressive disorder | 0.803 | 0.532–3.048 | 0.298 | 0.813 | 0.521–2.984 | 0.288 |
HR, hazard ratio; CI, confidence interval; Adjusted HR: Adjusted for gender, age, comorbidities, urbanization level, location, and insured premium.